APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duck Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Duck Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchDuck Vaccines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Duck Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Duck Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duck Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Duck Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Duck Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Duck Vaccines include CAHIC, Zoetis, Merck Animal Health, Yebio, Vaksindo, Ringpu Biology, Harbin Veterinary Research Institute, FATRO and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Duck Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Duck Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Duck Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Duck Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Duck Vaccines Segment by Company

CAHIC

Zoetis

Merck Animal Health

Yebio

Vaksindo

Ringpu Biology

Harbin Veterinary Research Institute

FATRO

Elanco

CEVA

CAVAC

Boehringer Ingelheim

Duck Vaccines Segment by Type

Attenuated Live Vaccines

Killed Vaccines

Duck Vaccines Segment by Application

Avian Influenza Vaccine

Newcastle Disease Vaccine

Other

Duck Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duck Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Duck Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Duck Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Duck Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Duck Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Duck Vaccines Industry Trends Table 2. Duck Vaccines Industry Drivers Table 3. Duck Vaccines Industry Opportunities and Challenges Table 4. Duck Vaccines Industry Restraints Table 5. Global Duck Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Duck Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Duck Vaccines Sales by Manufacturers (m units) & (2021-2026) Table 8. Global Duck Vaccines Sales Market Share by Manufacturers Table 9. Global Duck Vaccines Average Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 10. Global Duck Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Duck Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Duck Vaccines Manufacturers, Product Type & Application Table 13. Global Duck Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Duck Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Attenuated Live Vaccines Table 17. Major Manufacturers of Killed Vaccines Table 18. Global Duck Vaccines Sales by Type 2021 VS 2025 VS 2032 (m units) Table 19. Global Duck Vaccines Sales by Type (2021-2026) & (m units) Table 20. Global Duck Vaccines Sales by Type (2027-2032) & (m units) Table 21. Global Duck Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Duck Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Duck Vaccines Revenue by Type 2021 VS 2025 VS 2032 (m units) Table 24. Global Duck Vaccines Revenue by Type (2021-2026) & (m units) Table 25. Global Duck Vaccines Revenue by Type (2027-2032) & (m units) Table 26. Global Duck Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Duck Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Avian Influenza Vaccine Table 29. Major Manufacturers of Newcastle Disease Vaccine Table 30. Major Manufacturers of Other Table 31. Global Duck Vaccines Sales by Application 2021 VS 2025 VS 2032 (m units) Table 32. Global Duck Vaccines Sales by Application (2021-2026) & (m units) Table 33. Global Duck Vaccines Sales by Application (2027-2032) & (m units) Table 34. Global Duck Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Duck Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Duck Vaccines Revenue by Application 2021 VS 2025 VS 2032 (m units) Table 37. Global Duck Vaccines Revenue by Application (2021-2026) & (m units) Table 38. Global Duck Vaccines Revenue by Application (2027-2032) & (m units) Table 39. Global Duck Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Duck Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Duck Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 42. Global Duck Vaccines Sales by Region (2021-2026) & (m units) Table 43. Global Duck Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Duck Vaccines Sales Forecasted by Region (2027-2032) & (m units) Table 45. Global Duck Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 47. North America Duck Vaccines Sales by Country (2021-2026) & (m units) Table 48. North America Duck Vaccines Sales by Country (2027-2032) & (m units) Table 49. Europe Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 50. Europe Duck Vaccines Sales by Country (2021-2026) & (m units) Table 51. Europe Duck Vaccines Sales by Country (2027-2032) & (m units) Table 52. Asia Pacific Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 53. Asia Pacific Duck Vaccines Sales by Country (2021-2026) & (m units) Table 54. Asia Pacific Duck Vaccines Sales by Country (2027-2032) & (m units) Table 55. South America, Middle East and Africa Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 56. South America, Middle East and Africa Duck Vaccines Sales by Country (2021-2026) & (m units) Table 57. South America, Middle East and Africa Duck Vaccines Sales by Country (2027-2032) & (m units) Table 58. Global Duck Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Duck Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Duck Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Duck Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Duck Vaccines Revenue Market Share by Region (2027-2032) Table 63. CAHIC Company Information Table 64. CAHIC Business Overview Table 65. CAHIC Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CAHIC Duck Vaccines Product Portfolio Table 67. CAHIC Recent Development Table 68. Zoetis Company Information Table 69. Zoetis Business Overview Table 70. Zoetis Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zoetis Duck Vaccines Product Portfolio Table 72. Zoetis Recent Development Table 73. Merck Animal Health Company Information Table 74. Merck Animal Health Business Overview Table 75. Merck Animal Health Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Animal Health Duck Vaccines Product Portfolio Table 77. Merck Animal Health Recent Development Table 78. Yebio Company Information Table 79. Yebio Business Overview Table 80. Yebio Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Yebio Duck Vaccines Product Portfolio Table 82. Yebio Recent Development Table 83. Vaksindo Company Information Table 84. Vaksindo Business Overview Table 85. Vaksindo Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Vaksindo Duck Vaccines Product Portfolio Table 87. Vaksindo Recent Development Table 88. Ringpu Biology Company Information Table 89. Ringpu Biology Business Overview Table 90. Ringpu Biology Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ringpu Biology Duck Vaccines Product Portfolio Table 92. Ringpu Biology Recent Development Table 93. Harbin Veterinary Research Institute Company Information Table 94. Harbin Veterinary Research Institute Business Overview Table 95. Harbin Veterinary Research Institute Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Harbin Veterinary Research Institute Duck Vaccines Product Portfolio Table 97. Harbin Veterinary Research Institute Recent Development Table 98. FATRO Company Information Table 99. FATRO Business Overview Table 100. FATRO Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. FATRO Duck Vaccines Product Portfolio Table 102. FATRO Recent Development Table 103. Elanco Company Information Table 104. Elanco Business Overview Table 105. Elanco Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Elanco Duck Vaccines Product Portfolio Table 107. Elanco Recent Development Table 108. CEVA Company Information Table 109. CEVA Business Overview Table 110. CEVA Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CEVA Duck Vaccines Product Portfolio Table 112. CEVA Recent Development Table 113. CAVAC Company Information Table 114. CAVAC Business Overview Table 115. CAVAC Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CAVAC Duck Vaccines Product Portfolio Table 117. CAVAC Recent Development Table 118. Boehringer Ingelheim Company Information Table 119. Boehringer Ingelheim Business Overview Table 120. Boehringer Ingelheim Duck Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim Duck Vaccines Product Portfolio Table 122. Boehringer Ingelheim Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Duck Vaccines Distributors List Table 126. Duck Vaccines Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Duck Vaccines Product Image Figure 2. Global Duck Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duck Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Duck Vaccines Sales (2021-2032) & (m units) Figure 5. Global Duck Vaccines Average Price (US$/k unit) & (2021-2032) Figure 6. Global Top 5 and 10 Duck Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Attenuated Live Vaccines Image Figure 9. Killed Vaccines Image Figure 10. Global Duck Vaccines Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 11. Global Duck Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Duck Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Duck Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (m units) Figure 14. Global Duck Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Duck Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Avian Influenza Vaccine Image Figure 17. Newcastle Disease Vaccine Image Figure 18. Other Image Figure 19. Global Duck Vaccines Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 20. Global Duck Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Duck Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Duck Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (m units) Figure 23. Global Duck Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Duck Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 26. North America Duck Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 28. Canada Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 29. Mexico Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 30. Europe Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 31. Europe Duck Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 33. France Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 34. U.K. Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 35. Italy Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 36. Netherlands Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 37. Asia Pacific Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 38. Asia Pacific Duck Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 40. Japan Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 41. South Korea Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 42. Southeast Asia Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 43. India Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 44. Australia Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 45. South America, Middle East and Africa Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 46. South America, Middle East and Africa Duck Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 48. South Africa Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 49. Saudi Arabia Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 50. Turkey Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 51. Argentina Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 52. UAE Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 53. Egypt Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 54. Chile Duck Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 55. Global Duck Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Duck Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Duck Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Duck Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Duck Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Duck Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Duck Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Duck Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Live Vaccines
  • Killed Vaccines
Applications
  • Avian Influenza Vaccine
  • Newcastle Disease Vaccine
  • Other
Companies covered
  • CAHIC
  • Zoetis
  • Merck Animal Health
  • Yebio
  • Vaksindo
  • Ringpu Biology
  • Harbin Veterinary Research Institute
  • FATRO
  • Elanco
  • CEVA
  • CAVAC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Duck Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Duck Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Duck Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Duck Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Duck Vaccines Market Dynamics
  1. 2.1 Duck Vaccines Industry Trends
  2. 2.2 Duck Vaccines Industry Drivers
  3. 2.3 Duck Vaccines Industry Opportunities and Challenges
  4. 2.4 Duck Vaccines Industry Restraints
3 Duck Vaccines Market by Manufacturers
  1. 3.1 Global Duck Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Duck Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Duck Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Duck Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Duck Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Duck Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Duck Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Duck Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Duck Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Duck Vaccines Tier 1, Tier 2, and Tier 3
4 Duck Vaccines Market by Type
  1. 4.1 Duck Vaccines Type Introduction
  2. 4.1.1 Attenuated Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Duck Vaccines Sales by Type
  5. 4.2.1 Global Duck Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Duck Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Duck Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Duck Vaccines Revenue by Type
  9. 4.3.1 Global Duck Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Duck Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Duck Vaccines Revenue Market Share by Type (2021-2032)
5 Duck Vaccines Market by Application
  1. 5.1 Duck Vaccines Application Introduction
  2. 5.1.1 Avian Influenza Vaccine
  3. 5.1.2 Newcastle Disease Vaccine
  4. 5.1.3 Other
  5. 5.2 Global Duck Vaccines Sales by Application
  6. 5.2.1 Global Duck Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Duck Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Duck Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Duck Vaccines Revenue by Application
  10. 5.3.1 Global Duck Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Duck Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Duck Vaccines Revenue Market Share by Application (2021-2032)
6 Global Duck Vaccines Sales by Region
  1. 6.1 Global Duck Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Duck Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Duck Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Duck Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Duck Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Duck Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Duck Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Duck Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Duck Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Duck Vaccines Revenue by Region
  1. 7.1 Global Duck Vaccines Revenue by Region
  2. 7.1.1 Global Duck Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Duck Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Duck Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Duck Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Duck Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Duck Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Duck Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Duck Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Duck Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Duck Vaccines Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Duck Vaccines Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Duck Vaccines Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Yebio
  20. 8.4.1 Yebio Company Information
  21. 8.4.2 Yebio Business Overview
  22. 8.4.3 Yebio Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yebio Duck Vaccines Product Portfolio
  24. 8.4.5 Yebio Recent Developments
  25. 8.5 Vaksindo
  26. 8.5.1 Vaksindo Company Information
  27. 8.5.2 Vaksindo Business Overview
  28. 8.5.3 Vaksindo Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vaksindo Duck Vaccines Product Portfolio
  30. 8.5.5 Vaksindo Recent Developments
  31. 8.6 Ringpu Biology
  32. 8.6.1 Ringpu Biology Company Information
  33. 8.6.2 Ringpu Biology Business Overview
  34. 8.6.3 Ringpu Biology Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ringpu Biology Duck Vaccines Product Portfolio
  36. 8.6.5 Ringpu Biology Recent Developments
  37. 8.7 Harbin Veterinary Research Institute
  38. 8.7.1 Harbin Veterinary Research Institute Company Information
  39. 8.7.2 Harbin Veterinary Research Institute Business Overview
  40. 8.7.3 Harbin Veterinary Research Institute Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Veterinary Research Institute Duck Vaccines Product Portfolio
  42. 8.7.5 Harbin Veterinary Research Institute Recent Developments
  43. 8.8 FATRO
  44. 8.8.1 FATRO Company Information
  45. 8.8.2 FATRO Business Overview
  46. 8.8.3 FATRO Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FATRO Duck Vaccines Product Portfolio
  48. 8.8.5 FATRO Recent Developments
  49. 8.9 Elanco
  50. 8.9.1 Elanco Company Information
  51. 8.9.2 Elanco Business Overview
  52. 8.9.3 Elanco Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Elanco Duck Vaccines Product Portfolio
  54. 8.9.5 Elanco Recent Developments
  55. 8.10 CEVA
  56. 8.10.1 CEVA Company Information
  57. 8.10.2 CEVA Business Overview
  58. 8.10.3 CEVA Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CEVA Duck Vaccines Product Portfolio
  60. 8.10.5 CEVA Recent Developments
  61. 8.11 CAVAC
  62. 8.11.1 CAVAC Company Information
  63. 8.11.2 CAVAC Business Overview
  64. 8.11.3 CAVAC Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CAVAC Duck Vaccines Product Portfolio
  66. 8.11.5 CAVAC Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Duck Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Duck Vaccines Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Duck Vaccines Value Chain Analysis
  2. 9.1.1 Duck Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Duck Vaccines Production Mode & Process
  6. 9.2 Duck Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Duck Vaccines Distributors
  9. 9.2.3 Duck Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst